Clinical Trial Update: A Study of Safety and Efficacy of MK-1986 (Tedizolid Phosphate) and Comparator in Participants From Birth to Less Than 12 Years of Age With Acute Bacterial Skin and Skin Structure Infections (MK-1986-018) [Phase 3]

View source ↗

Summary

A Phase 3 pediatric trial evaluating Tedizolid Phosphate (MK-1986) versus a comparator for acute bacterial skin and skin structure infections in children from b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bacterial Skin and Skin Structure Infections

Drugs mentioned

• Tedizolid Phosphate (MK-1986) (tedizolid phosphate)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Acute Bacterial Skin and Skin Structure Infections | Phase 3 | Status: COMPLETED | Results posted: 2024-07-03